|
FY2025
12 months to Sep 27, 2025
|
FY2024
12 months to Sep 28, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Oct 1, 2022
|
FY2021
12 months to Oct 2, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash flows from operating activities: | |||||
| Depreciation and amortization | |||||
| Share-based compensation expense and related charges | |||||
| Provision for allowance for doubtful accounts | |||||
| Asset impairment charges | |||||
| Deferred income tax benefit | |||||
| Other, net | |||||
| Changes in operating assets and liabilities, excluding impacts of currency: | |||||
| Accounts receivable | |||||
| Contract assets | |||||
| Inventories | |||||
| Other current and non-current assets | |||||
| Accrued income taxes payable | |||||
| Accounts payable | |||||
| Advanced payments from customers | |||||
| Other current and non-current liabilities | |||||
| Cash flows provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Payments for property, plant and equipment | |||||
| Proceeds from insurance | |||||
| Other, net | |||||
| Cash flows used in investing activities | |||||
| Cash flows from financing activities | |||||
| Borrowings under debt agreements | |||||
| Payments on debt and finance lease obligations | |||||
| Debt issuance costs | |||||
| Repurchases of common stock | |||||
| Proceeds from exercise of stock options | |||||
| Payments related to tax withholding for share-based compensation | |||||
| Cash flows used in financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease) increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash: | |||||
| Beginning of period | |||||
| End of period | |||||
| Supplemental disclosure information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
Loading...